Island Pharmaceuticals Ltd (ASX:ILA) has successfully enrolled its first subjects for a Phase 2b clinical trial to test the ...

Progression to the phase 2b cohort follows recommendation of the Safety Review Committee (SRC) after it reviewed positive ...

The role of antiviral drugs in the treatment of dengue fever has been limited, but is currently widely studied. Focusing on the natural characteristics of dengue, this acute febrile illness can be ...

Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA)  CEO and managing director David Foster to get the short end of the long story on the company’s latest news.

The main treatment is supportive and symptomatic treatment by fluid-replacement therapy. Discovery of a new antiviral drug for dengue is the best hope for treatment.

Infections have increased dramatically over the past two years while, at the same time, developers of anti-dengue drugs and vaccines have abandoned their research and development efforts.

The "Dengue Fever - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of the Dengue Fever Clinical trials scenario ...

Island Pharmaceuticals (ASX:ILA), an Australian antiviral drug development company, has announced the granting of a US patent ... portfolio and provides enhanced protection for our flagship program, ...

Some diseases that have spread over the last few decades are untreatable with medicines. Recovery banks heavily on immunity & ...

With four strains of dengue and no widespread vaccine or antiviral drug, medical experts urge travelers to take preventative measures. Aedes aegypti mosquitoes, which can also carry yellow fever ...

Medical experts say you can still visit dengue hot spots such as Puerto Rico, Argentina and Brazil. But bring repellent.